<DOC>
	<DOC>NCT01029522</DOC>
	<brief_summary>A multi-center, randomized, double-blinded equivalence clinical trial to evaluate efficacy and safety of LipiLou 20 mg versus Lipitor 20 mg in hypercholesterolemic patients with higher risk cardiovascular disease in Korea.</brief_summary>
	<brief_title>Dyslipidemia in Cardiovascular Disease</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>1. Dyslipidemic patients with highrisk cardiovascular disease meeting more than 1 requirement below (LDLC ≥ 100mg/dL) 1) Coronary artery disease diagnosed with atheroma in Coronary CT or Angiography, or SPECT positive or Treadmill test positive 2) Diabetes Mellitus 3) intervened with stent in coronary artery disease more than 1 year before 4) diagnosed with atheroma in carotid artery 5) Peripheral artery disease 2. Aged 20~85 years 3. Volunteers consented with participating clinical trial and submitted consent paper 1. Experimental examination at screening 1) Active liver disease or more than 2 x ULN of AST/ALT 2) Creatine Kinase &gt; 2 x ULN 3) Creatinine &gt; 2.5mg/dL 4) Triglycerides &gt; 500mg/dL 2. intervened with stent in coronary artery disease less than 1 year before 3. Hypersensitive or resistant to other HMGCoA reductase inhibitors, or experienced serious adverse events 4. Patients taking dyslipidemic treatments within 4 weeks (HMGCoA reductase inhibitors, fibrates, nicotinic acids or bile acid resins, etc.) 5. As uncontrolled DM patients, HbA1c≥11% or fasting plasma glucose ≥200mg/dL 6. DBP &gt; 100mmHg, SBP &gt; 160mmHg 7. Diagnosed with myopathy 8. Appear to be a risk of myopathy below renal impairment or prior renal dysfunction hypothyroidism genetic defects or family history of myopathy experienced prior muscle toxicity with taking statins or fibrates prior liver disease or higher intakes of alcohol aged over 70, and a risk of myopathy 9. Women pregnant or breastfeeding 10. Women capable of pregnancy without using contraceptives 11. contraindicated medically or mentally, or forbidden legally 12. Enrolled to other clinical trial within 4 weeks 13. Impossible to participate clinical trial according to investigator's decision</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Dyslipidemia</keyword>
</DOC>